1. Effect of the beta-lactamase inhibitor vaborbactam combined with meropenem against serine carbapenemase-producing Enterobacteriaceae;Castanheira;Antimicrob Agents Chemother,2016
2. Antibiotic resistance threats in the United States;CDC,2013
3. Efficacy, safety, tolerability of carbavance compared to piperacillin/tazobactam in complicated urinary tract infections (cUTIs), including acute pyelonephritis (AP), in adults;ClincalTrials.gov,2016
4. Efficacy, safety, tolerability of carbavance compared to best available therapy in serious infections due to carbapenem resistant Enterobacteriaceae, in adults;ClincalTrials.gov,2017
5. M07-A10;CLSI,2015